search icon

    Market Snapshot

    • S&P Futures

      4,132

    • Dow Futures

      32,804

    • Nasdaq Futures

      13,053.75

    blog search icon

    AIM ImmunoTech Inc.

    (AMEX:AIM)

    $0.74

    -$0.01

    -0.78%

    AIM ImmunoTech Inc. Chart

    AIM Stock Price Today

    AIM ImmunoTech Inc. (AIM) stock declined over -0.78% intraday to trade at $0.7392 a share on AMEX. The stock opened with a loss of -0.11% at $0.715 and touched an intraday high of $0.75, rising 1.26% against the last close of $0.73. The stock went to a low of $0.701 during the session.

    Stock Snapshot

    $0.73

    Prev. Close

    35.86 Million

    Market Cap

    $0.701

    Day Low

    $0.715

    Open

    47.99 Million

    Number of Shares

    $0.75

    Day High

    -

    P/E ratio

    -0.40

    EPS (TTM)

    0.93

    Cash Flow per Share

    1.16

    Free Float in %

    1.28

    Book Value

    27,714

    Volume

    AIM ImmunoTech Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$0.715$0.75$0.701$0.745103,602
    2022-08-05$0.74$0.74$0.71$0.7396,700
    2022-08-04$0.69$0.73$0.69$0.73100,800
    2022-08-03$0.7$0.71$0.69$0.7124,900
    2022-08-02$0.73$0.73$0.69$0.7187,000
    2022-08-01$0.76$0.76$0.69$0.74318,300
    2022-07-29$0.72$0.75$0.71$0.73136,800
    2022-07-28$0.77$0.81$0.71$0.72334,300
    2022-07-27$0.73$0.75$0.71$0.74136,400
    2022-07-26$0.74$0.75$0.72$0.72140,200

    Contact Details

    2117 SW Highway 484
    Ocala, FL 34473
    United States

    Webiste:AIM

    352 448 7797

    Company Information

    Employees-

    Beta-0.47

    Sales or Revenue140 Thousands

    5Y Sales Change8%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat genital warts, a sexually transmitted disease. It has agreements with UMN Pharma Inc.; Japanese National Institute of Infectious Diseases; Shionogi & Co., Ltd.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

    Frequently Asked Questions

    icon

    What is the current AIM ImmunoTech Inc. (AIM) stock price?

    AIM ImmunoTech Inc. (AMEX: AIM) stock price is $0.7392 as of the last check on Monday, August 8. During the trading session, AIM stock reached the peak price of $0.75 while $0.701 was the lowest point it dropped to.

    icon

    AIM's industry and sector of operation?

    The AMEX listed AIM is part of Biotechnology industry that operates in the broader Health Care sector. AIM ImmunoTech Inc. , an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

    icon

    Who are the executives of AIM?

    Mr. Thomas K. Equels Esq., J.D., M.S.
    Exec. Vice Chairman, CEO & Pres
    Mr. Peter W. Rodino III, Esq., J.D.
    COO, Exec. Director of Gov.al Relations, Gen. Counsel & Sec.
    Mr. Robert Dickey IV, M.B.A.
    Chief Financial Officer
    Dr. David R. Strayer M.D.
    Chief Scientific Officer & Medical Director

    icon

    What is the AIM stock price today?

    AIM stock traded closed the last session at $0.745, which is -$0.005800000000000027 or -0.7785234899328896% lower than its previous close of $0.73. AIM's current trading price is 35.45% lower than its 52-week high of $2.2 where as its distance from 52-week low of 0.55% is -66.14%.

    icon

    How many employees does AIM have?

    Number of AIM employees currently stands at -. AIM operates from 2117 SW Highway 484, Ocala, FL 34473, United States.

    icon

    Link for AIM official website?

    Official Webiste of $AIM is: https://www.aimimmuno.com

    icon

    How do I contact AIM?

    AIM could be contacted at AIM operates from 2117 SW Highway 484, Ocala, FL 34473, United States, or at phone #352 448 7797 and can also be accessed through its website.

    icon

    How many shares of AIM are traded daily?

    AIM stock volume for the day was 27,714 shares while in the previous session number of AIM shares traded was 103,602 . The average number of AIM shares traded daily for last 3 months was 169.68 Thousands.

    icon

    How much did AIM change today?

    The percentage change in AIM stock occurred in the recent session was -0.7785234899328896% while the dollar amount for the price change in AIM stock was -$0.005800000000000027.

    icon

    What price range AIM stock been trading in?

    In the recent session, the day high for AIM stock was $0.75 while the low for AIM stock touched on the day was $0.701.

    icon

    What is the market cap of AIM currently?

    The market value of AIM currently stands at 35.86 Million with its latest stock price at $0.7392 and 47.99 Million of its shares outstanding.